Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show, Webcast

UroGen Pharma to Present at Upcoming Investor Conferences


UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will present at the following investor conferences in March:

Cowen 43rd Annual Health Care Conference ? March 7-9, 2023

Oppenheimer 33rd Annual Healthcare Conference ? March 13-15, 2023

Webcasts for both the Cowen and Oppenheimer presentations will be available via the Investors section of UroGen's website, www.urogen.com. A replay of each webcast will be available on the Company's website for approximately 30 days.

About UroGen Pharma Ltd.

UroGen is biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers because patients deserve better options. UroGen has developed RTGeltm reverse-thermal hydrogel, a proprietary sustained release, hydrogel-based platform technology that has the potential to improve therapeutic profiles of existing drugs. UroGen's sustained release technology is designed to enable longer exposure of the urinary tract tissue to medications, making local therapy a potentially more effective treatment option. UroGen's first commercial product JELMYTO (mitomycin) for pyelocalyceal solution, and investigational treatment UGN-102 (mitomycin) for intravesical solution for patients with low-grade non-muscle invasive bladder cancer, are designed to ablate tumors by non-surgical means. UroGen is headquartered in Princeton, NJ with operations in Israel. Visit www.urogen.com to learn more or follow us on Twitter, @UroGenPharma.


These press releases may also interest you

at 19:35
Fobi AI Announces Amendment to Asset Purchase Agreement with Wallet Communications SL
Fobi AI Inc. (FOBI:TSXV) (FOBIF:OTCQB) (the "Company" or "Fobi"), an industry leader in harnessing AI and data intelligence to enable digital transformation, is pleased to announce that, further to its press release dated October 18, 2023, it has...

at 19:00
Autohome Inc. to Hold Annual General Meeting on June 21, 2024
Autohome Inc. ("Autohome" or the "Company"), the leading online destination for automobile consumers in China, today announced that it will hold its annual general meeting of shareholders (the "AGM") at 18th Floor Tower B, CEC Plaza, 3 Dan Ling...

at 19:00
Avid Controls Ensures Continuous Support for the Entire GEPC/Converteam MV3000 Product Line
Avid Controls is an authorized licensed manufacturer of the GEPC/Converteam MV3000 product line, and is dedicated to providing world-class support to customers for the entire lifespan of their equipment. The MV3000 modules provide reliable ancillary...

at 18:36
MikeWorldWide Bolsters Digital Strategy Team with Promotions, New Leadership
MikeWorldWide, a leading New York-based, independent public relations agencies with offices across the US and UK has promoted Megan Hueter to lead digital practice and created two new vice president positions to strengthen functional expertise in...

at 18:30
TechTarget's Enterprise Strategy Group Adds Industry Veteran Jim Frey to Lead Networking Coverage, Research and Analysis
TechTarget's Enterprise Strategy Group, a leading IT analyst, research, and strategy firm, today announced the addition of Jim Frey as Principal Analyst to lead the firm's coverage of the networking market. Frey will be covering networking and...

at 18:03
Ferrovial and DXC Technology to drive Generative AI in collaboration with Microsoft
Ferrovial has teamed up with U.S. technology consulting firm DXC Technology to jointly develop the platform known as Quercus to accelerate and scale the adoption of Generative Artificial Intelligence (AI) across the infrastructure company's...

More news about Science and technology...


News published on and distributed by: